These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 1375595

  • 1. Temocillin and cystic fibrosis: outcome of intravenous administration in patients infected with Pseudomonas cepacia.
    Taylor RF, Gaya H, Hodson ME.
    J Antimicrob Chemother; 1992 Mar; 29(3):341-4. PubMed ID: 1375595
    [Abstract] [Full Text] [Related]

  • 2. Temocillin in the treatment of Burkholderia cepacia infection in cystic fibrosis.
    Lekkas A, Gyi KM, Hodson ME.
    J Cyst Fibros; 2006 May; 5(2):121-4. PubMed ID: 16650744
    [Abstract] [Full Text] [Related]

  • 3. Temocillin in cystic fibrosis: a retrospective pilot study.
    Kent L, Bradley JM, France M, Döring G, Carryn S, Bradbury I, Rendall J, Jones A, Elborn JS.
    J Cyst Fibros; 2008 Nov; 7(6):551-4. PubMed ID: 18706868
    [Abstract] [Full Text] [Related]

  • 4. Antibody response to Burkholderia cepacia in patients with cystic fibrosis colonized with Burkholderia cepacia and Pseudomonas aeruginosa.
    Hendry J, Butler S, Elborn JS, Govan JR, Nelson J, Shale DJ, Webb AK.
    J Infect; 2000 Mar; 40(2):164-70. PubMed ID: 10841094
    [Abstract] [Full Text] [Related]

  • 5. The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way?
    Banerjee D, Stableforth D.
    Drugs; 2000 Nov; 60(5):1053-64. PubMed ID: 11129122
    [Abstract] [Full Text] [Related]

  • 6. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem.
    Isles A, Maclusky I, Corey M, Gold R, Prober C, Fleming P, Levison H.
    J Pediatr; 1984 Feb; 104(2):206-10. PubMed ID: 6420530
    [Abstract] [Full Text] [Related]

  • 7. Carbenicillin and gentamicin: pharmacologic studies in patients with cystic fibrosis and pseudomonas pulmonary infections.
    Marks MI, Prentice R, Swarson R, Cotton EK, Eickhoff TC.
    J Pediatr; 1971 Nov; 79(5):822-8. PubMed ID: 5000612
    [No Abstract] [Full Text] [Related]

  • 8. Pseudomonas cepacia in the sputum of cystic fibrosis patients.
    Taylor PC, Kalamatianos CC.
    Pathology; 1994 Jul; 26(3):315-7. PubMed ID: 7527513
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of antibiotic treatment on inflammatory markers and lung function in cystic fibrosis patients with Pseudomonas cepacia.
    Peckham D, Crouch S, Humphreys H, Lobo B, Tse A, Knox AJ.
    Thorax; 1994 Aug; 49(8):803-7. PubMed ID: 7522353
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Two case reports of the successful eradication of new isolates of Burkholderia cepacia complex in children with cystic fibrosis.
    Kitt H, Lenney W, Gilchrist FJ.
    BMC Pharmacol Toxicol; 2016 Mar 28; 17():14. PubMed ID: 27018049
    [Abstract] [Full Text] [Related]

  • 15. Sputum antibiotic concentrations: implications for treatment of cystic fibrosis lung infection.
    Moriarty TF, McElnay JC, Elborn JS, Tunney MM.
    Pediatr Pulmonol; 2007 Nov 28; 42(11):1008-17. PubMed ID: 17902147
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.